Skip to main content


Fig. 7 | Cardiovascular Diabetology

Fig. 7

From: The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial

Fig. 7

a Shows adiponectin values from visit 1 to visit 3. Saxagliptin showed a decrease throughout the study, after visit 2, while the placebo group increased steadily from visit 1 to visit 3 (p = 0.01). b Shows serum creatinine values from visit 1 to visit 3. There is a steep decline from visit 1 to 2 in the placebo group, while levels remain stable in the saxagliptin group (p = 0.12)

Back to article page